Zacks Equity Research Analyst Blog
Zacks Equity Research Analyst Blog
Visit Zacks Equity Research Analyst Blog
Posted 1 week ago
The company operates in an intensely competitive landscape. It faces competition from large, multinational ERP vendors such as Oracle.
Posted 1 week ago
Recent commodity inflation is pressuring margins and the trend is expected to continue at least through 2008.
Tags: inflation
Posted 1 week ago
We initiate coverage of SOL with a Buy recommendation and a six-month target price of $24.25.
Posted 1 week ago
The company is now in the third year of the plan and the brand-building process is proving to be successful.
Posted 1 week ago
There could be significant upside to our estimates as our model does not include any potential milestone or upfront payments.
Tags: pipeline
Posted 1 week ago
Competition has intensified over the last few years in the online employment advertising market, which in our view has resulted in Monster losing share.
Tags: online
Posted 1 week ago
We expect revenue growth to significantly slow due to the presence of generic Adderall XR.
Tags: pharma
Posted 1 week ago
We feel the firm will trade at current to slightly higher valuation metrics until the 2008-2009 demand outlook becomes a little more clear.
Posted 1 week ago
While we are optimistic on the companys development pipeline, both candidates are still years from commercialization.
Tags: pipeline
Posted 1 week ago
Going forward, the diversified revenue stream should enable the company to post sustainable growth.




Subscribe to Zacks Equity Research Analyst Blog